Publications - William J . Hogan, M.D.

Back to Research Profile

1. Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Hogan WJ, Markovic SN. New onset lymphopenia assessed during routine follow-up is a risk factor for relapse post-autologous peripheral blood hematopoietic stem cell transplantation in patients with diffuse large B-cell lymphoma. Biol Blood Marrow Transplant 2009 Oct 30. [Epub ahead of print]
   View PubMed
2. Tefferi A, Lasho TL, Patnaik MM, Finke CM, Hussein K, Hogan WJ, Elliott MA, Litzow MR, Hanson CA, Pardanani A. JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival. Leukemia 2009 Oct 22. [Epub ahead of print]
   View PubMed
3. Eid AJ, Brown RA, Hogan WJ, Lahr BD, Eckel-Passow JE, Litzow MR, Razonable RR. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2009 Sep 09. [Epub ahead of print]
   View PubMed
4. Halfdanarson TR, Kumar N, Hogan WJ, Murray JA. Copper deficiency in celiac disease. J Clin Gastroenterol 2009 Feb; 43(2):162-4.
   View PubMed
5. Gertz MA, Ansell SM, Dingli D, Dispenzieri A, Buadi FK, Elliott MA, Gastineau DA, Hayman SR, Hogan WJ, Inwards DJ, Johnston PB, Kumar S, Lacy MQ, Leung N, Micallef IN, Porrata LF, Schafer BA, Wolf RC, Litzow MR. Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative. Mayo Clin Proc 2008 Oct; 83(10):1131-8.
   View PubMed
6. Malhotra P, Hogan WJ, Litzow MR, Elliott MA, Gastineau DA, Ansell SM, Dispenzieri A, Gertz MA, Hayman SR, Inwards DJ, Lacy MQ, Micallef IN, Porrata LF, Tefferi A. Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 years. Leuk Lymphoma 2008 Sep; 49(9):1724-30.
   View PubMed
7. Halfdanarson TR, Kumar N, Li CY, Phyliky RL, Hogan WJ. Hematological manifestations of copper deficiency: a retrospective review. Eur J Haematol 2008 Jun; 80(6):523-31. Epub 2008 Feb 12.
   View PubMed
8. Dispenzieri A, Lacy MQ, Hayman SR, Kumar SK, Buadi F, Dingli D, Litzow MR, Gastineau DA, Inwards DJ, Elliott MA, Micallef IN, Ansell SM, Hogan WJ, Porrata LF, Johnston PA, Afessa B, Bryce A, Kyle RA, Gertz MA. Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome. Eur J Haematol 2008 May; 80(5):397-406. Epub 2008 Jan 23.
   View PubMed
9. Perri R, Assi M, Talwalkar J, Heimbach J, Hogan W, Moore SB, Rosen CB. Graft vs. host disease after liver transplantation: a new approach is needed. Liver Transpl 2007 Aug; 13(8):1092-9.
   View PubMed
10. Butler AE, Huang A, Rao PN, Bhushan A, Hogan WJ, Rizza RA, Butler PC. Hematopoietic stem cells derived from adult donors are not a source of pancreatic beta-cells in adult nondiabetic humans. Diabetes 2007 Jul; 56(7):1810-6. Epub 2007 Apr 24.
    View PubMed
11. Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, Wadleigh M, Steensma DP, Elliott MA, Wolanskyj AP, Hogan WJ, McClure RF, Litzow MR, Gilliland DG, Tefferi A. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood 2006 Nov 15; 108(10):3472-6. Epub 2006 Jul 25.
    View PubMed
12. Keegan MT, Nygren E, Afessa B, Hogan WJ, Harrison BA. Is there a role for inhaled nitric oxide as a rescue therapy in respiratory failure associated with hematologic malignancies? Am J Hematol 2006 Oct; 81(10):729-34.
    View PubMed
13. Yunusov MY, Kuhr CS, Georges GE, Hogan WJ, Taranova AG, Lesnikova M, Kim YS, Abrams K, Hwang B, Sale GE, Storer B, Storb R, Nash RA. Partial donor-specific tolerance to delayed skin grafts after rejection of hematopoietic cell graft. Transplantation 2006 Sep 15; 82(5):629-37.
14. Zent CS, Call TG, Hogan WJ, Shanafelt TD, Kay NE. Update on risk-stratified management for chronic lymphocytic leukemia. Leuk Lymphoma 2006 Sep; 47(9):1738-46.
    View PubMed
15. Tefferi A, Cortes J, Verstovsek S, Mesa RA, Thomas D, Lasho TL, Hogan WJ, Litzow MR, Allred JB, Jones D, Byrne C, Zeldis JB, Ketterling RP, McClure RF, Giles F, Kantarjian HM. Lenalidomide therapy in myelofibrosis with myeloid metaplasia. Blood 2006 Aug 15; 108(4):1158-64. Epub 2006 Apr 11.
    View PubMed
16. Elliott MA, Tefferi A, Hogan WJ, Letendre L, Gastineau DA, Ansell SM, Dispenzieri A, Gertz MA, Hayman SR, Inwards DJ, Lacy MQ, Micallef IN, Porrata LF, Litzow MR. Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia. Bone Marrow Transplant 2006 Jun; 37(11):1003-8.
    View PubMed
17. Halfdanarson TR, Hogan WJ, Moynihan TJ. Oncologic emergencies: diagnosis and treatment. Mayo Clin Proc 2006 Jun; 81(6):835-48.
    View PubMed
18. Lacy MQ, Hogan WJ, Gertz MA, Dispenzieri A, Rajkumar SV, Hayman S, Kumar S, Litzow MR, Schroeter AL. Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation. Arch Dermatol 2005 Oct; 141(10):1277-82.
    View PubMed
19. Yoong Y, Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Litzow MR, Gertz MA, Lacy MQ, Dispenzieri A, Gastineau DA, Tefferi A, Elliott M, Snow DS, Hogan WJ, Markovic SN. The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma. Leuk Lymphoma 2005 Sep; 46(9):1287-94.
    View PubMed
20. Porrata LF, Gertz MA, Litzow MR, Lacy MQ, Dispenzieri A, Inwards DJ, Ansell SM, Micallef INM, Gastineau DA, Elliott M, Hogan WJ, Hayman SR, Tefferi A, Markovic SN. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis. Clin Cancer Res 2005 Feb 1; 11(3):1210-8.
    View PubMed
21. Dispenzieri A, Moreno-Aspitia A, Suarez GA, Lacy MQ, Colon-Otero G, Tefferi A, Litzow MR, Roy V, Hogan WJ, Kyle RA, Gertz MA. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome: and a review of the literature. Blood 2004 Nov 15; 104(10):3400-7.
    View PubMed
22. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, McConnell JP, Litzow MR, Gastineau DA, Tefferi A, Inwards DJ, Micallef IN, Ansell SM, Porrata LF, Elliott MA, Hogan WJ, Rajkumar SV, Fonseca R, Greipp PR, Witzig TE, Lust JA, Zeldenrust S Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood 2004 Sep 15; 104(6):1881-7.
    View PubMed
23. Hogan WJ, Storb R. Use of cyclosporine in hematopoietic cell transplantation. Transplant Proc 2004 Mar; 36(2 Suppl S):367S-371S.
    View PubMed
24. Hogan WJ, Maris M, Storer B, Sandmaier BM, Maloney D, Schoch G, Woolfrey A, Shulman H, Storb R, McDonald GB. Hepatic Injury after Nonmyeloablative Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation: A Study of 193 Patients. Blood 2004 Jan 1`; 103(1):78-84.
    View PubMed
25. Lee R, Kuhr CS, Sale GE, Zellmer E, Hogan WJ, Storb R, Little MT. FTY720 does not Abrogate Acute Graft-Versus-Host-Disease in the DLA-Non Identical Unrelated Canine Model. Transplantation October 27, 2003; 76(8):1155-8.
    View PubMed
26. Hogan WJ, Storb R. Therapeutic Applications of Non-Myeloablative Hematopoietic Stem Cell Transplantation in Malignant Disease. Immunologic Research Aug 2003; 28(1):1-12.
    View PubMed
27. Hogan WJ, Little MT, Zellmer E, Friedetzky A, Diaconescu R, Gisburn S, Lee R, Kuhr CS, Storb R. Postgrafting immunosuppression with sirolimus and cyclosporine facilitate stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation. Biology of Blood and Marrow Transplantation Aug 2003; 9(8):489-95.
    View PubMed
28. Hogan WJ, Storb R. Clinical Developments with Non-Myeloablative Haematopoietic Stem Cell Transplantation. Expert Opinion on Biological Therapy 2 (7) 703-714, Oct 2002.
    View PubMed
29. Hogan WJ, Letendre L, Litzow MR, Tefferi A, Hoagland HC, Pruthi RK, Kaufmann SH. Neutropenic colitis after treatment of acute myelogenous leukemia with idarubicin and cytosine arabinoside. Mayo Clin Proc 2002 Aug; 77(8):760-2.
    View PubMed
30. Hogan WJ, Edwards WD, Macon WR, Habermann TM. Fulminant hepatic failure secondary to adenovirus following fludarabine-based chemotherapy for non-Hodgkin's lymphoma. Leuk Lymphoma 2001 Sep-Oct; 42(5):1145-50.
    View PubMed
31. Hogan WJ, Lacy MQ, Wiseman GA, Fealey RD, Dispenzieri A, Gertz MA. Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation. Bone Marrow Transplant 2001 Aug; 28(3):305-309.
    View PubMed
32. Hogan WJ, Kay NE. 87-year-old man with macrocytic anemia. Mayo Clin Proc 2001 Feb; 76(2):201-4.
    View PubMed
33. Hogan WJ, McBane RD, Santrach PJ, Plumhoff EA, Oliver WC Jr, Schaff HV, Rodeheffer RJ, Edwards WD, Duffy J, Nichols WL. Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery. Mayo Clin Proc 2000 Sep; 75(9):971-6.
    View PubMed
34. Hogan WJ, Tefferi A, Borell TJ, Jenkins R, Li CY, Witzig TE. Prognostic relevance of monosomy at the 13q14 locus detected by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia. Cancer Genetics & Cytogenetics 1999 Apr 15; 110(2):77-81.
    View PubMed